a 50 mcg dose at that concentration is 0.10 mL (10 units on a U-100 insulin syringe)
Common Side Effects When side effects occurred, they were typically mild, transient, and similar in frequency to placebo groups: Reported Adverse Effects Most Common (occurring in small percentage of participants): Mild to moderate headaches (most frequently reported, often resolving with continued use) Injection site reactions (minor redness, swelling, or irritation at injection site) Gastrointestinal effects (particularly at higher oral doses: mild nausea, diarrhea, flatulence) Fatigue (reported occasionally during initial adaptation period) Rare Events: One case of chest tightness was deemed possibly related to treatment in safety trials
Unlike many other peptide therapies, GHK-Cu typically isnt administered as an injectable
The temperature treatments included the non-stress control, for which plants were maintained in growth chambers at 25/20 C (day/night, optimum), and heat stress, where plants were maintained at 35/30 C (day/night)
